Multidrug-Resistant Tuberculosis Disease in North-Kivu Province, Democratique Republic of Congo*Corresponding Author: Mashako Ruhanga Many, Goma Higher Technical Medical Institute and Expert of Health Provincial Ministry of North-Kivu Province, Central Africa, Email: [email protected]
Received Date: Mar 26, 2019 / Accepted Date: Apr 30, 2019 / Published Date: May 07, 2019
Citation: Robert BN, Many MR (2019) Multidrug–Resistant Tuberculosis Disease in North-Kivu Province, Democratique Republic of Congo. J Tuberc Ther 4: 120.
Copyright: © 2019 Robert BN, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Introduction: The emergency of Mycobacterium tuberculosis resistant to the first line drug, limited access to second line drugs for appropriate treatment and calls for urgent action especially in le Democratic Republic of Congo (DRC), which it’s accounts among the highest Tuberculosis (TB) burden countries in Africa.
Aims and Objectives: To present prevalence and describe multidrug-resistant tuberculosis cases in North-Kivu Province identified by using Genexpert technology.
Methods: We conducted an observational prospective study on Multidrug-Resistant Tuberculosis (MDR-TB) cases in North-Kivu Province, DRC from 2017to 2018. All cases of MDR-TB identified by Genexpert MTB/RIB was included in this series.
Results: Of 15,544 tuberculosis cases registered during the study period, 19 cases of MDR-TB were identified. 57.9% was male, 89.5% was retreatment cases and 5.3% was coinfection HIV/TB cases.
Conclusions: This new molecular technology diagnostic, facilitates multidrug-resistance tuberculosis detection and improves the reporting of data lack.